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Introduction
Back pain is a major public health problem in Western
industrialized societies. It causes suffering and distress to
patients and their families, and affects a large number of
people; the point prevalence rates in a number of studies
ranged from 12% to 35% [1], with around 10% of suffer-
ers becoming chronically disabled. It also places an enor-
mous economic burden on society; its total cost, including
direct medical costs, insurance, lost production and dis-
ability benefits, is estimated at £12 billion per annum in
the UK and 1.7% of the gross national product in The
Netherlands [1,2].
Back pain is strongly associated with degeneration of the
intervertebral disc [3]. Disc degeneration, although in
many cases asymptomatic [4], is also associated with sci-
atica and disc herniation or prolapse. It alters disc height
and the mechanics of the rest of the spinal column, possi-
bly adversely affecting the behaviour of other spinal struc-
tures such as muscles and ligaments. In the long term it
can lead to spinal stenosis, a major cause of pain and dis-
ability in the elderly; its incidence is rising exponentially
with current demographic changes and an increased aged
population.
Discs degenerate far earlier than do other musculoskeletal
tissues; the first unequivocal findings of degeneration in
the lumbar discs are seen in the age group 11–16 years
[5]. About 20% of people in their teens have discs with
mild signs of degeneration; degeneration increases
steeply with age, particularly in males, so that around 10%
of 50-year-old discs and 60% of 70-year-old discs are
severely degenerate [6].
In this short review we outline the morphology and bio-
chemistry of normal discs and the changes that arise
during degeneration. We review recent advances in our
understanding of the aetiology of this disorder and
discuss new approaches to treatment.
Disc morphology
The normal disc
The intervertebral discs lie between the vertebral bodies,
linking them together (Fig.1). They are the main joints of
the spinal column and occupy one-third of its height. Their
major role is mechanical, as they constantly transmit loads
arising from body weight and muscle activity through the
spinal column. They provide flexibility to this, allowing
bending, flexion and torsion. They are approximately
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7–10mm thick and 4cm in diameter (anterior–posterior
plane) in the lumbar region of the spine [7,8]. The interver-
tebral discs are complex structures that consist of a thick
outer ring of fibrous cartilage termed the annulus fibrosus,
which surrounds a more gelatinous core known as the
nucleus pulposus; the nucleus pulposus is sandwiched
inferiorly and superiorly by cartilage end-plates.
The central nucleus pulposus contains collagen fibres,
which are organised randomly [9], and elastin fibres
(sometimes up to 150µm in length), which are arranged
radially [10]; these fibres are embedded in a highly
hydrated aggrecan-containing gel. Interspersed at a low
density (approximately 5000/mm3 [11]) are chondrocyte-
like cells, sometimes sitting in a capsule within the matrix.
Outside the nucleus is the annulus fibrosus, with the
boundary between the two regions being very distinct in
the young individual (<10 years).
The annulus is made up of a series of 15–25 concentric
rings, or lamellae [12], with the collagen fibres lying paral-
lel within each lamella. The fibres are orientated at approxi-
mately 60° to the vertical axis, alternating to the left and
right of it in adjacent lamellae. Elastin fibres lie between
the lamellae, possibly helping the disc to return to its origi-
nal arrangement following bending, whether it be flexion or
extension. They may also bind the lamellae together as
elastin fibres pass radially from one lamella to the next
[10]. The cells of the annulus, particularly in the outer
region, tend to be fibroblast-like, elongated, thin and
aligned parallel to the collagen fibres. Toward the inner
annulus the cells can be more oval. Cells of the disc, both
in the annulus and nucleus, can have several long, thin
cytoplasmic projections, which may be more than 30µm
long [13,14] (WEB Johnson, personal communication).
Such features are not seen in cells of articular cartilage
[13]. Their function in disc is unknown but it has been sug-
gested that they may act as sensors and communicators
of mechanical strain within the tissue [13].
The third morphologically distinct region is the cartilage
end-plate, a thin horizontal layer, usually less than 1mm
thick, of hyaline cartilage. This interfaces the disc and the
vertebral body. The collagen fibres within it run horizontal
and parallel to the vertebral bodies, with the fibres continu-
ing into the disc [8].
The healthy adult disc has few (if any) blood vessels, but it
has some nerves, mainly restricted to the outer lamellae,
some of which terminate in proprioceptors [15]. The carti-
laginous end-plate, like other hyaline cartilages, is normally
totally avascular and aneural in the healthy adult. Blood
vessels present in the longitudinal ligaments adjacent to
the disc and in young cartilage end-plates (less than about
12 months old) are branches of the spinal artery [16].
Nerves in the disc have been demonstrated, often accom-
panying these vessels, but they can also occur indepen-
dently, being branches of the sinuvertebral nerve or
derived from the ventral rami or grey rami communicantes.
Some of the nerves in discs also have glial support cells,
or Schwann cells, alongside them [17].
Degenerated discs
During growth and skeletal maturation the boundary
between annulus and nucleus becomes less obvious, and
with increasing age the nucleus generally becomes more
fibrotic and less gel-like [18]. With increasing age and
degeneration the disc changes in morphology, becoming
more and more disorganized (Fig.2). Often the annular
lamellae become irregular, bifurcating and interdigitating,
and the collagen and elastin networks also appear to
become more disorganised (J Yu, personal communication).
There is frequently cleft formation with fissures forming
within the disc, particularly in the nucleus. Nerves and
blood vessels are increasingly found with degeneration
[15]. Cell proliferation occurs, leading to cluster formation,
particularly in the nucleus [19,20]. Cell death also occurs,
with the presence of cells with necrotic and apoptotic
appearance [21,22]. These mechanisms are apparently
very common; it has been reported that more than 50% of
cells in adult discs are necrotic [21]. The morphological
changes associated with disc degeneration were compre-
hensively reviewed recently by Boos et al. [5], who
demonstrated an age-associated change in morphology,
with discs from individuals as young as 2 years of age
having some very mild cleft formation and granular
changes to the nucleus. With increasing age comes an
Figure 1
A schematic view of a spinal segment and the intervertebral disc. The
figure shows the organization of the disc with the nucleus pulposus
(NP) surrounded by the lamellae of the annulus fibrosus (AF) and
separated from the vertebral bodies (VB) by the cartilaginous end-plate
(CEP). The figure also shows the relationship between the
intervertebral disc and the spinal cord (SC), the nerve root (NR), and
the apophyseal joints (AJ).122
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increased incidence of degenerative changes, including
cell death, cell proliferation, mucous degeneration, granu-
lar change and concentric tears. It is difficult to differenti-
ate changes that occur solely due to ageing from those
that might be considered ‘pathological’.
Biochemistry
Normal discs
The mechanical functions of the disc are served by the
extracellular matrix; its composition and organization
govern the disc’s mechanical responses. The main
mechanical role is provided by the two major macromolec-
ular components. The collagen network, formed mostly of
type I and type II collagen fibrils and making up approxi-
mately 70% and 20% of the dry weight of the annulus and
nucleus, respectively [23], provides tensile strength to the
disc and anchors the tissue to the bone. Aggrecan, the
major proteoglycan of the disc [24], is responsible for
maintaining tissue hydration through the osmotic pressure
provided by its constituent chondroitin and keratan sul-
phate chains [25]. The proteoglycan and water content of
the nucleus (around 50% and 80% of the wet weight,
respectively) is greater than in the annulus (approximately
20% and 70% of the wet weight, respectively). In addition,
there are many other minor components, such as collagen
types III, V, VI, IX, X, XI, XII and XIV; small proteoglycans
such as lumican, biglycan, decorin and fibromodulin; and
other glycoproteins such as fibronectin and amyloid
[26,27]. The functional role of many of these additional
matrix proteins and glycoproteins is not yet clear. Collagen
IX, however, is thought to be involved in forming cross-
links between collagen fibrils and is thus important in
maintaining network integrity [28].
The matrix is a dynamic structure. Its molecules are contin-
ually being broken down by proteinases such as the matrix
metalloproteinases (MMPs) and aggrecanases, which are
also synthesized by disc cells [29–31]. The balance
between synthesis, breakdown and accumulation of matrix
macromolecules determines the quality and integrity of the
matrix, and thus the mechanical behaviour of the disc
itself. The integrity of the matrix is also important for main-
taining the relatively avascular and aneural nature of the
healthy disc.
The intervertebral disc is often likened to articular carti-
lage, and indeed it does resemble it in many ways, particu-
larly in the biochemical components present. However,
there are significant differences between the two tissues,
one of these being the composition and structure of
aggrecan. Disc aggrecan is more highly substituted with
keratan sulphate than that found in the deep zone of artic-
ular cartilage. In addition, the aggrecan molecules are less
aggregated (30%) and more heterogeneous, with smaller,
more degraded fragments in the disc than in articular carti-
lage (80% aggregated) from the same individual [32].
Disc proteoglycans become increasingly difficult to extract
from the matrix with increasing age [24]; this may be due
to extensive cross-linking, which appears to occur more
within the disc matrix than in other connective tissues.
Changes in disc biochemistry with degeneration
The most significant biochemical change to occur in disc
degeneration is loss of proteoglycan [33]. The aggrecan
molecules become degraded, with smaller fragments
being able to leach from the tissue more readily than
larger portions. This results in loss of glycosaminoglycans;
this loss is responsible for a fall in the osmotic pressure of
the disc matrix and so a loss of hydration.
Even in degenerate discs, however, the disc cells can
retain the ability to synthesize large aggrecan molecules,
with intact hyaluronan-binding regions, which have the
potential to form aggregates [24]. Less is known of how
the small proteoglycan population changes with disc
degeneration, although there is some evidence that the
amount of decorin, and more particularly biglycan, is ele-
vated in degenerate human discs as compared with
normal ones [34].
Although the collagen population of the disc also changes
with degeneration of the matrix, the changes are not as
obvious as those of the proteoglycans. The absolute quan-
tity of collagen changes little but the types and distribution
of collagens can alter. For example, there may be a shift in
proportions of types of collagens found and in their appar-
ent distribution within the matrix. In addition, the fibrillar
collagens, such as type II collagen, become more dena-
tured, apparently because of enzymic activity. As with pro-
teoglycans, the triple helices of the collagens are more
denatured and ruptured than are those found in articular
cartilage from the same individual; the amount of dena-
tured type II collagen increases with degeneration [35,36].
However, collagen cross-link studies indicate that, as with
proteoglycans, new collagen molecules may be synthe-
Figure 2
The normal and degenerate lumbar intervertebral disc. The figure
shows a normal intervertebral disc on the left. The annulus lamellae
surrounding the softer nucleus pulposus are clearly visible. In the
highly degenerate disc on the right, the nucleus is desiccated and the
annulus is disorganized.123
sized, at least early in disc degeneration, possibly in an
attempt at repair [37].
Other components can change in disc degeneration and
disease in either quantity or distribution. For example,
fibronectin content increases with increasing degenera-
tion and it becomes more fragmented [38]. These ele-
vated levels of fibronectin could reflect the response of the
cell to an altered environment. Whatever the cause, the
formation of fibronectin fragments can then feed into the
degenerative cascade because they have been shown to
downregulate aggrecan synthesis but to upregulate the
production of some MMPs in in vitro systems.
The biochemistry of disc degeneration indicates that enzy-
matic activity contributes to this disorder, with increased
fragmentation of the collagen, proteoglycan and fibronectin
populations. Several families of enzymes are capable of
breaking down the various matrix molecules of disc, includ-
ing cathepsins, MMPs and aggrecanases. Cathepsins have
maximal activity in acid conditions (e.g. cathepsin D is inac-
tive above pH 7.2). In contrast, MMPs and aggrecanases
have an optimal pH that is approximately neutral. All of
these enzymes have been identified in disc, with higher
levels of, for example, MMPs in more degenerate discs
[39]. Cathepsins D and L and several types of MMPs
(MMP-1, -2, -3, -7, -8, -9 and -13) occur in human discs;
they may be produced by the cells of the disc themselves
as well as by the cells of the invading blood vessels. Aggre-
canases have also been shown to occur in human disc but
their activity is apparently less obvious, at least in more
advanced disc degeneration [29,30,40].
Effect of degenerative changes on disc
function and pathology
The loss of proteoglycan in degenerate discs [33] has a
major effect on the disc’s load-bearing behaviour. With loss
of proteoglycan, the osmotic pressure of the disc falls [41]
and the disc is less able to maintain hydration under load;
degenerate discs have a lower water content than do
normal age-matched discs [33], and when loaded they
lose height [42] and fluid more rapidly, and the discs tend
to bulge. Loss of proteoglycan and matrix disorganization
have other important mechanical effects; because of the
subsequent loss of hydration, degenerated discs no longer
behave hydrostatically under load [43]. Loading may thus
lead to inappropriate stress concentrations along the end-
plate or in the annulus; the stress concentrations seen in
degenerate discs have also been associated with disco-
genic pain produced during discography [44].
Such major changes in disc behaviour have a strong influ-
ence on other spinal structures, and may affect their func-
tion and predispose them to injury. For instance, as a
result of the rapid loss of disc height under load in degen-
erate discs, apophyseal joints adjacent to such discs
(Fig.1) may be subject to abnormal loads [45] and eventu-
ally develop osteoarthritic changes. Loss of disc height
can also affect other structures. It reduces the tensional
forces on the ligamentum flavum and hence may cause
remodelling and thickening. With consequent loss of elas-
ticity [46], the ligament will tend to bulge into the spinal
canal, leading to spinal stenosis – an increasing problem
as the population ages.
Loss of proteoglycans also influences the movement of
molecules into and out of the disc. Aggrecan, because of
its high concentration and charge in the normal disc, pre-
vents movement of large uncharged molecules such as
serum proteins and cytokines into and through the matrix
[47]. The fall in concentration of aggrecan in degeneration
could thus facilitate loss of small, but osmotically active,
aggrecan fragments from the disc, possibly accelerating a
degenerative cascade. In addition, loss of aggrecan would
allow increased penetration of large molecules such as
growth factor complexes and cytokines into the disc,
affecting cellular behaviour and possibly the progression
of degeneration. The increased vascular and neural
ingrowth seen in degenerate discs and associated with
chronic back pain [48] is also probably associated with
proteoglycan loss because disc aggrecan has been
shown to inhibit neural ingrowth [49,50].
Disc herniation
The most common disc disorder presenting to spinal sur-
geons is herniated or prolapsed intervertebral disc. In these
cases the discs bulge or rupture (either partially or totally)
posteriorly or posterolaterally, and press on the nerve roots
in the spinal canal (Fig.1). Although herniation is often
thought to be the result of a mechanically induced rupture,
it can only be induced in vitro in healthy discs by mechani-
cal forces larger than those that are ever normally encoun-
tered; in most experimental tests, the vertebral body fails
rather than the disc [51]. Some degenerative changes
seem necessary before the disc can herniate; indeed,
examination of autopsy or surgical specimens suggest that
sequestration or herniation results from the migration of
isolated, degenerate fragments of nucleus pulposus
through pre-existing tears in the annulus fibrosus [52].
It is now clear that herniation-induced pressure on the
nerve root cannot alone be the cause of pain because
more than 70% of ‘normal’, asymptomatic people have
disc prolapses pressurizing the nerve roots but no pain
[4,53]. A past and current hypothesis is that, in sympto-
matic individuals, the nerves are somehow sensitized to
the pressure [54], possibly by molecules arising from an
inflammatory cascade from arachodonic acid through to
prostaglandin E2, thromboxane, phospholipase A2, tumour
necrosis factor-α, the interleukins and MMPs. These mole-
cules can be produced by cells of herniated discs [55],
and because of the close physical contact between the
Available online http://arthritis-research.com/content/5/3/120124
nerve root and disc following herniation they may be able
to sensitize the nerve root [56,57]. The exact sequence of
events and specific molecules that are involved have not
been identified, but a pilot study of sciatic patients treated
with tumour necrosis factor-α antagonists is encouraging
and supports this proposed mechanism [58,59]. However,
care must be exercised in interrupting the inflammatory
cascade, which can also have beneficial effects. Mole-
cules such as MMPs, which are produced extensively in
prolapsed discs [30], almost certainly play a major role in
the natural history of resorbing the offending herniation.
Aetiology of disc degeneration
Disc degeneration has proved a difficult entity to study; its
definition is vague, with diffuse parameters that are not
always easy to quantify. In addition, there is a lack of a
good animal model. There are significant anatomical differ-
ences between humans and the laboratory animals that
are traditionally used as models of other disorders. In par-
ticular, the nucleus differs; in rodents as well as many
other mammals, the nucleus is populated by notochordal
cells throughout adulthood, whereas these cells disappear
from the human nucleus after infancy [60]. In addition,
although the cartilage end-plate in humans acts as a
growth plate for the vertebral body, in most animals the
vertebrae have two growth plates within the vertebral body
itself, and the cartilage end-plate is a much thinner layer
than that found in humans. Thus, although the study of
animals that develop degeneration spontaneously [61,62]
and of injury models of degeneration [63,64] have pro-
vided some insight into the degenerative processes, most
information on aetiology of disc degeneration to date has
come from human studies.
Nutritional pathways to disc degeneration
One of the primary causes of disc degeneration is thought
to be failure of the nutrient supply to the disc cells [65].
Like all cell types, the cells of the disc require nutrients
such as glucose and oxygen to remain alive and active.
In vitro, the activity of disc cells is very sensitive to extra-
cellular oxygen and pH, with matrix synthesis rates falling
steeply at acidic pH and at low oxygen concentrations
[66,67], and the cells do not survive prolonged exposure
to low pH or glucose concentrations [68]. A fall in nutrient
supply that leads to a lowering of oxygen tension or of pH
(arising from raised lactic acid concentrations) could thus
affect the ability of disc cells to synthesize and maintain
the disc’s extracellular matrix and could ultimately lead to
disc degeneration.
The disc is large and avascular and the cells depend on
blood vessels at their margins to supply nutrients and
remove metabolic waste [69]. The pathway from the blood
supply to the nucleus cells is precarious because these
cells are supplied virtually entirely by capillaries that origi-
nate in the vertebral bodies, penetrating the subchondral
plate and terminating just above the cartilaginous end-
plate [16,70]. Nutrients must then diffuse from the capillar-
ies through the cartilaginous end-plate and the dense
extracellular matrix of the nucleus to the cells, which may
be as far as 8 mm from the capillary bed.
The nutrient supply to the nucleus cells can be disturbed at
several points. Factors that affect the blood supply to the
vertebral body such as atherosclerosis [71,72], sickle cell
anaemia, Caisson disease and Gaucher’s disease [73] all
appear to lead to a significant increase in disc degenera-
tion. Long-term exercise or lack of it appears to have an
effect on movement of nutrients into the disc, and thus on
their concentration in the tissue [74,75]. The mechanism is
not known but it has been suggested that exercise affects
the architecture of the capillary bed at the disc–bone inter-
face. Finally, even if the blood supply remains undisturbed,
nutrients may not reach the disc cells if the cartilaginous
end-plate calcifies [65,76]; intense calcification of the end-
plate is seen in scoliotic discs [77], for instance. Distur-
bances in nutrient supply have been shown to affect
transport of oxygen and lactic acid into and out of the disc
experimentally [78] and in patients [79].
Although little information is available to relate nutrient
supply to disc properties in patients, a relationship has been
found between loss of cell viability and a fall in nutrient
transport in scoliotic discs [80,81]. There is also some evi-
dence that nutrient transport is affected in disc degenera-
tion in vivo [82], and the transport of solutes from bone to
disc measured in vitro was significantly lower in degenerate
than in normal discs [65]. Thus, although there is as yet little
direct evidence, it now seems apparent that a fall in nutrient
supply will ultimately lead to degeneration of the disc.
Mechanical load and injury
Abnormal mechanical loads are also thought to provide a
pathway to disc degeneration. For many decades it was
suggested that a major cause of back problems is injury,
often work-related, which causes structural damage. It is
believed that such an injury initiates a pathway that leads
to disc degeneration and finally to clinical symptoms and
back pain [83]. Animal models have supported this
finding. Although intense exercise does not appear to
affect discs adversely [84] and discs are reported to
respond to some long-term loading regimens by increas-
ing proteoglycan content [85], experimental overloading
[86] or injury to the disc [63,87] can induce degenerative
changes. Further support for the role of abnormal mechan-
ical forces in disc degeneration comes from findings that
disc levels adjacent to a fused segment degenerate
rapidly (for review [88]).
This injury model is also supported by many epidemiologi-
cal studies that have found associations between environ-
mental factors and development of disc degeneration and
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herniation, with heavy physical work, lifting, truck-driving,
obesity and smoking found to be the major risk factors for
back pain and degeneration [89–91]. As a result of these
studies, there have been many ergonomic interventions in
the workplace [91]. However, the incidence of disc
degeneration-related disorders has continued to rise
despite these interventions. Over the past decade, as
magnetic resonance imaging has refined classifications of
disc degeneration [5,92], it has become evident that,
although factors such as occupation, psychosocial
factors, benefit payments and environment are linked to
disabling back pain [93,94], contrary to previous assump-
tions these factors have little influence on the pattern of
disc degeneration itself [95,96]. This illustrates the
tenuous relationship between degeneration and clinical
symptoms.
Genetic factors in disc degeneration
More recent work suggested that the factors that lead to
disc degeneration may have important genetic compo-
nents. Several studies have reported a strong familial pre-
disposition for disc degeneration and herniation [97–99].
Findings from two different twin studies conducted during
the past decade showed heritability exceeding 60%
[100,101]. Magnetic resonance images in identical twins,
who were discordant for major risk factors such as
smoking or heavy work, were very similar with respect to
the spinal columns and the patterns of disc degeneration
(Fig.3) [102].
Genetic predisposition has been confirmed by recent find-
ings of associations between disc degeneration and gene
polymorphisms of matrix macromolecules. The approach
to date has been via searching for candidate genes, with
the main focus being extracellular matrix genes. Although
there is a lack of association between disc degeneration
and polymorphisms of the major collagens in the disc, col-
lagen types I and II [103], mutations of two collagen
type IX genes, namely COL9A2 and COL9A3, have been
found to be strongly associated with lumbar disc degener-
ation and sciatica in a Finnish population [104,105]. The
COL9A2 polymorphism is found only in a small percent-
age of the Finnish population, but all individuals with this
allele had disc degenerative disorders, suggesting that it
is associated with a dominantly inherited disease. In both
these mutations, tryptophan (the most hydrophobic amino
acid, which is not normally found in any collagenous
domain) substituted for other amino acids, potentially
affecting matrix properties [103].
Other genes associated with disc generation have also
been identified. Individuals with a polymorphism in the
aggrecan gene were found to be at risk for early disc
degeneration in a Japanese study [106]. This mutation
leads to aggrecan core proteins of different lengths, with
an over-representation of core proteins able to bind only a
low number of chondroitin sulfate chains among those with
severe disc degeneration. Presumably these individuals
have a lower chondroitin sulfate content than normal, and
their discs will behave similarly to degenerate discs that
have lost proteoglycan by other mechanisms. Studies of
transgenic mice have also demonstrated that mutations in
structural matrix molecules such as aggrecan [107], colla-
gen II [108] and collagen IX [109] can lead to disc degen-
eration. Mutations in genes other than those of structural
matrix macromolecules have also been associated with
disc degeneration. A polymorphism in the promoter region
of the MMP-3 gene was associated with rapid degenera-
tion in elderly Japanese subjects [110]. In addition, two
polymorphisms of the vitamin D receptor gene were the
first mutations shown to be associated with disc degenera-
tion [111–114]. The mechanism of vitamin D receptor
gene polymorphism involvement in disc degeneration is
unknown, but at present it does not appear to be related to
differences in bone density [111,112,114].
All of the genetic mutations associated with disc degener-
ation to date have been found using a candidate gene
approach and all, apart from the vitamin D receptor poly-
morphism, are concerned with molecules that determine
the integrity and function of the extracellular matrix.
However, mutations in other systems such as signalling or
metabolic pathways could lead to changes in cellular
activity that may ultimately result in disc degeneration
[115]. Different approaches may be necessary to identify
such polymorphisms. Genetic mapping, for instance, has
identified a susceptibility locus for disc herniation, but the
gene involved has not yet been identified [116].
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Figure 3
Magnetic resonance images of the lumbar discs of 44-year-old
identical twins. Note similarities in the contours of the end-plates,
particularly at L1–L2 (white arrow head). The spines also show similar
degenerative changes in the disc, particularly at L4–L5 (white arrow).
From [102], with kind permission from the authors and publishers.126
In summary, the findings from these genetic and epidemio-
logical studies point to the multifactorial nature of disc
degeneration. It is evident now that mutations in several
different classes of genes may cause the changes in
matrix morphology, disc biochemistry and disc function
typifying disc degeneration. Identification of the genes
involved may lead to improved diagnostic criteria; for
example, it is already apparent that the presence of spe-
cific polymorphisms increase the risk for disc bulge,
annular tears, or osteophytes [112,117]. However,
because of the evidence for gene–environment interac-
tions [97,114,118], genetic studies in isolation are unlikely
to delineate the various pathways of disc degeneration.
New therapies
Current treatments attempt to reduce pain rather than
repair the degenerated disc. The treatments used
presently are mainly conservative and palliative, and are
aimed at returning patients to work. They range from
bedrest (no longer recommended) to analgesia, the use of
muscle relaxants or injection of corticosteroids, or local
anaesthetic and manipulation therapies. Various interven-
tions (e.g. intradiscal electrotherapy) are also used, but
despite anecdotal statements of success trials thus far
have found their use to be of little direct benefit [119].
Disc degeneration-related pain is also treated surgically
either by discectomy or by immobilization of the affected
vertebrae, but surgery is offered only to one in every 2000
back pain episodes in the UK; the incidence of surgical
treatment is five times higher in the USA [93]. The
success rates of all these procedures are generally similar.
Although a recent study indicated that surgery improves
the rate of recovery in well selected patients [120],
70–80% of patients with obvious surgical indications for
back pain or disc herniation eventually recover, whether
surgery is carried out or not [121,122].
Because disc degeneration is thought to lead to degener-
ation of adjacent tissues and be a risk factor in the devel-
opment of spinal stenosis in the long term, new treatments
are in development that are aimed at restoring disc height
and biomechanical function. Some of the proposed bio-
logical therapies are outlined below.
Cell based therapies
The aim of these therapies is to achieve cellular repair of
the degenerated disc matrix. One approach has been to
stimulate the disc cells to produce more matrix. Growth
factors can increase rates of matrix synthesis by up to five-
fold [123,124]. In contrast, cytokines lead to matrix loss
because they inhibit matrix synthesis while stimulating pro-
duction of agents that are involved in tissue breakdown
[125]. These proteins have thus provided targets for
genetic engineering. Direct injection of growth factors or
cytokine inhibitors has proved unsuccessful because their
effectiveness in the disc is short-lived. Hence gene-
therapy is now under investigation; it has the potential to
maintain high levels of the relevant growth factor or
inhibitor in the tissue. In gene therapy, the gene of interest
(e.g. one responsible for producing a growth factor such
as transforming growth factor-β or inhibiting interleukin-1)
is introduced into target cells, which then continue to
produce the relevant protein (for review [126]). This
approach has been shown to be technically feasible in the
disc, with gene transfer increasing transforming growth
factor-β production by disc cells in a rabbit nearly sixfold
[127]. However, this therapy is still far from clinical use.
Apart from the technical problems of delivery of the genes
into human disc cells, the correct choice of therapeutic
genes requires an improved understanding of the patho-
genesis of degeneration. In addition, the cell density in
normal human discs is low, and many of the cells in
degenerate discs are dead [21]; stimulation of the remain-
ing cells may be insufficient to repair the matrix.
Cell implantation alone or in conjunction with gene therapy
is an approach that may overcome the paucity of cells in a
degenerate disc. Here, the cells of the degenerate disc
are supplemented by adding new cells either on their own
or together with an appropriate scaffold. This technique
has been used successfully for articular cartilage
[128,129] and has been attempted with some success in
animal discs [130]. However, at present, no obvious
source of clinically useful cells exists for the human disc,
particularly for the nucleus, the region of most interest
[131]. Moreover, conditions in degenerate discs, particu-
larly if the nutritional pathway has been compromised [65],
may not be favourable for survival of implanted cells. Nev-
ertheless, autologous disc cell transfer has been used
clinically in small groups of patients [132], with initial
results reported to be promising, although few details of
the patients or outcome measures are available.
At present, although experimental work demonstrates the
potential of these cell-based therapies, several barriers
prevent the use of these treatments clinically. Moreover,
these treatments are unlikely to be appropriate for all
patients; some method of selecting appropriate patients
will be required if success with these therapies is to be
realized.
Conclusion
Disorders associated with degeneration of the interverte-
bral disc impose an economic burden similar to that of
coronary heart disease and greater than that of other
major health problems such as diabetes, Alzheimer’s
disease and kidney diseases [1,133]. New imaging tech-
nologies, and advances in cell biology and genetics
promise improved understanding of the aetiology, more
specific diagnoses and targeted treatments for these
costly and disabling conditions. However, the interverte-
bral disc is poorly researched, even in comparison with
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other musculoskeletal systems (Table 1). Moreover, the
research effort in, for instance, the kidney in comparison
with that in the disc is completely disparate to the relative
costs of the disorders associated with each organ and the
number of people affected. Unless more research atten-
tion is attracted to interverterbal disc biology, little will
come from these new technologies, and back pain will
remain as it is at present – a poorly diagnosed and poorly
treated syndrome that reduces the quality of life of a signif-
icant proportion of the population.
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